Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Oct 07, 2023

U.S. FDA Issues Complete Response Letter For Proposed Biosimilar Insulin Aspart: Biocon

USFDA issues complete response letter for proposed biosimilar Insulin Aspart: Biocon

U.S. FDA Issues Complete Response Letter For Proposed Biosimilar Insulin Aspart: Biocon
(Source: Biocon website)

Biotechnology major Biocon on Saturday said the U.S. health regulator has issued a complete response letter for Biocon Biologics' application for Insulin Aspart, a proposed biosimilar for diabetes treatment.

The U.S. Food and Drug Administration has issued a Complete Response Letter to convey to the company that its initial review of an application is complete, and it cannot approve the application in its present form.

"The CRL did not identify any outstanding scientific issues with the product. The CRL references the requirement for a satisfactory resolution of deficiencies from the pre-approval inspection of our Malaysia facility for Insulin Aspart, held in August 2022," Biocon spokesperson said in a regulatory filing.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

The company had submitted a comprehensive Corrective and Preventive Action plan in September 2022 that the agency found to be adequate and indicated that it would require a re-inspection of the Malaysia facility prior to the approval of the application, it added.

"The company will continue to engage with the USFDA for an expeditious resolution and approval of its biosimilar Insulin Aspart application. This decision has no impact on the manufacturing or distribution of the company's existing commercial portfolio," the spokesperson said.

Biocon Biologics is a subsidiary of Biocon Ltd.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices, Watch Business News Live and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Listen to the latest songs, only on JioSaavn.com